JRI 

Amir Sohrabi Corresponding Author
- Department of Virology, Faculty of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran
Alireza Samarbafzadeh
- Department of Virology, Faculty of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran
Manoochehr Makvandi
- Department of Virology, Faculty of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran
Sharif Maraghi
- Department of Parasitology, Faculty of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran
Taghi Razi
- Department of Obs & Gyn, Imam Khomeini Hospital, Jondishapour University of Medical Sciences, Ahvaz, Iran
Davood Darban
- Department of Virology, Faculty of Medicine, Jondishapour University of Medical Sciences, Ahvaz, Iran

Received: 7/1/2007 Accepted: 7/1/2007 - Publisher : Avicenna Research Institute

Related Articles

 

Other Format

 


Abstract

Introduction: Parvovirus B19, Toxoplasma gondii and Chlamydia trachomatis are the most common microorganisms which cause different sequela during pregnancy such as congenital aplasia, hydrops fetalis, abortion and other congenital anomalies in fetus (Such as neuro- ophthalmic complications). The purpose of this study was to determine the prevalence of these agents in pregnant women attending the Obs & Gyn ward of Imam Khomeini Hospital in Ahwaz, Iran. Materials & Methods: In this cross-sectional study, IgG against the mentioned microorganisms was assessed by ELISA method in the sera of 79 pregnant women attending Imam Khomeini Hospital in Ahwaz during a period of one month. In addition, a questionnaire was filled for each case and clinical data were entered. Finally, χ2 was calculated and the data were analyzed by SPSS (Version 11.5). P<0.05 was considered significant. results: 44 specimens (55.7%) from the 79 serum samples had igg against parvovirus b19, 28 samples (35.4%) against toxoplasma gondii and 8 samples (10%) against chlamydia tracho-matis. conclusion: the results demonstrated that>40% of the pregnant women did not have IgG against the mentioned agents, so they were vulnerable to infection by those microorganisms in ensuing pregnancies. Therefore, health education for pregnant women and screening for the mentioned microorganisms to prevent abortions and birth of newborns with congenital anoma-lies should be addressed more attentively.


Keywords: Parvovirus B19, Toxoplasma gondii, Chlamydia trachomatis, Pregnant, Abortion, Congenital anomaly


To cite this article:


References

  1. Heegard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15(3):485-505.   [PubMed]
  2. Brooks GF, Butel JS, Morse SA. Jawetz, Melnick, Adelbergs Medical Microbiology. 21st Edition. New York: McGraw Hill. 2001;pp:306-60.
  3. مارکل ادوارد. انگل‌شناسی پزشکی مارکل، جان، کروتوسکی. ترجمه: فتح اللهی علیرضا. ويرايش اول. تهران: انتشارات ارجمند؛1380. صفحات: 63- 154.
  4. Ridgway L. Advences in the antimicrobial therapy of chlamydial genital infections. Infec. 1992;25:51-90.   [PubMed]
  5. مراغي شريف. انگل‌شناسي برای دانشجويان پيراپزشکي. ويرايش اول. قم: انتشارات دارالنشراسـلام؛ 1383. صفحات: 8-92.
  6. Beaman MH, Mccabe RE, Wang SY, Remington JS. Principles and practice of infectious diseases. 4th Edi-tion. New york: Churchill Livingston. 1995;pp:2455-75.
  7. Boyer MK, Remington SJ, Mcleod LR. Feigin, Cherry, Demmler Textbook of Pediatric Infectious Diseases. 5th Edition. Vol 2. USA: Saunders. 2004;pp:2755-60.
  8. Murray PR, Rosenthal KS, Pfaller MA. Medical Micro-biology. 5th Edition. Philadelphia: Elsevier. 2005;pp: 463-72.
  9. Numazaki K. Serological tests for Chlamydia tracho-matis infections. Clin Microbiol Rev. 1998;11:228-9.   [PubMed]
  10. Bax CJ, Mustsaers JA. Comparison of serological assays for detection of chlamydia trachomatis antibodi-es in different groups of obstetrical and gynecological. Clin Diag Lab Immun. 2003;10:174-6.   [PubMed]
  11. Eishubinger AM. Parvovirus B19 infection in preg-nancy. Inter Virology. 1998;47:178-84.   [PubMed]
  12. Komischke K, Searle K, Enders G. Maternal serum alpha-fetoprotein & human chorionic gonadotropin in pregnant women without fetal complications. Prenat Diagn. 1997;17:1039-46.   [PubMed]
  13. همكار رسول، سليمي وحيد، سعاتمند زهرا، نوروز بابایی زهرا، محمودیان شوشتری محمود، منوری حمید رضا و همكاران . شيوع سرمي آنتي‌بادي IgG عليه پاروويروس B19 در گروههاي سني مختلف در تهران. خلاصه مقالات دومين كنگره ويروس‌شناسي ايران. تهران 1382. صفحه: 45.
  14. Cunningham D, Rennels MB. Parvovirus B19 Infec-tion. Emedicine. 2004;2-10.
  15. Keshavarz H, Mamishi S, Daneshvar H. The Prevalence of Toxoplasma Infection in Hospitalized Patients in Selected Hospitals of Kerman. 2000;7(3):129-36.   [Abstract]
  16. امين منصور، كجباف محمد جواد. نقش باكتري كلاميديا تراكوماتيس در ايجاد ناباروري. مجله زنان، مامائي و نازائي. 1378، صفحات:20- 17.
  17. ميري مقدم ابراهيم، مرادي عبد الوهاب، كيخا فاطمه، محمدی مهری، عارفي صدیقه. پــاروويـروسB19 در خانـمهاي حامـله شـهر زاهدان. خلاصه مقالات دومين كنگره ويروس شناسي ايران. تهران 1382، صفحه: 43.
  18. ضياييان مازیار، رسولی منوچهر، البرزي عبد الوهاب. بررسي ميزان شيوع عفونت پاروويروس B19 در دختران در شرف ازدواج و بانوان باردار در حين زايمان و نوزادان آنها در شيراز. خلاصه مقالات دومين كنگره ويروس شناسي ايران. تهران 1382، صفحه: 275.
  19. Knowles SJ, Grundy K, Cahill I. Susceptibility to inf ectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health. 2004;7(4):344-8.   [PubMed]
  20. مرداني احمد، کشاورز حسین. بررسی سرواپيدميولوژيک عفونت توکسوپلاسمايی در خانمهای باردار و توکسوپلاسموز مادرزادی به روشهای IFA و ELISA در استان قم. خلاصه مقالات چهارمين همايش انگل شناسی ايران. مشهد، 1382، صفحه: 103.
  21. Durmaz R, Durmaz B, Tac I, Rafiq M. Seropositivity of toxoplasmosis among reproductive age women in Malatya, Turkey. Egypt Sac Parasital. 1995;25(3):693-80.   [PubMed]
  22. Jones JL, Kruzanmoran D, Wilson M, Mcquillan G, Navin T, Mcauley JB. Toxoplasma gondii infection in the united states: seroprovalence and risk factors. Am J Epidemio. 2001;154(4):357-65.   [PubMed]
  23. Bouratbine A, Silia E, Chahed MK, Aoun K, Ismail R. Seroepidemiologic profile of toxoplasmosis in northern Tunisis. Parasite. 2001;8(1):61-6.   [PubMed]
  24. Numazaki K, Kusaka T, Chiba S. Perinatal compli-cation is associated with seropositivity for chlamydia trachomatis pregnancy. Clin Infec Dis. 1996;23:208-9.   [PubMed]
  25. Genacay M, Koskiniemi M, Saikku P. Chlamydia tra-chomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infec Dis. 1995;211: 424-6.   [PubMed]
  26. Sweet RL, Landers DV, Walker C, Schachter J. Chla-mydia trachomatis infection and pregnancy outcom. Am J Obstec Gynecol. 1987;156:824-33.   [PubMed]
  27. Mol BW, Dijkman JB, Wertheim PJ, Lijmer F, Veen DV, Bossuyt PMM. The accuracy of serum chlamy-dia antibodies in the diagnosis of tubal pathology Ameta-analysis. Fertil Steril.1997;67:1031-7.   [PubMed]
  28. Bax CJ, Mustsaers JA. Comparison of serological assays for detection of Chlamydia trochomatis anti-bodies in different groups of obstetrical and gyneco-logical. Clin Diag Lab Immun. 2003;10:174-6.   [PubMed]

COPE
SID
NLM
AJMB
IJBMLE
IJBMLE

Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.